Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer rdcu.be/dQg5y Congrats Renu Eapen for leading this work just published in nature Reviews Urology Declan Murphy Lewis Au Nathan Lawrentschuk GU Cast | Urology podcast!

Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer out on Nature Reviews Urology High-risk localized #ProstateCancer is a formidable challenge due to its high rates of recurrence and metastasis despite curative attempts like surgery. The

Live on ProsTIC TV is our must-watch multidisciplinary panel presentation featuring: James Buteau, Louise Emmett, Michael Hofman, Sze Ting Lee, Daniel Moon, Sue Ping Thang, Sidney Levy, A/Prof. Shahneen Sandhu and George Hruby. Watch now or save this link👉 youtu.be/hjBMs_oS9_o

This one is special: learn from our multidisciplinary panel discussing some tricky cases... MIM Software

If you have a few moments to listen to this interview as a parent with your child. Possible one of the best post race interviews I have ever watched #PlayOn

Learn from Arun Azad on combination theranostics? Which combo will win? A rapidly evolving area with lots of data reading out over next few months and years...

Comparing PSMA ligands for #ProstateCancer imaging. Michael Hofman Peter Mac Cancer Centre joins Alicia Morgans, MD, MPH Dana-Farber to discuss advances in prostate cancer imaging and theranostics. #WatchNow on UroToday > bit.ly/3Yj0O7V

Prof Oliver Sartor presenting at Theranostics AANMS ... Nice slide on What we do not know from VISION.

At ⁦⁦Theranostics AANMS⁩ conference and realised how much theranostic drug development and therapy are already revolutionizing care for many diseases in adults and children ⁦Sze Ting Lee⁩ ⁦Michael Hofman⁩ ⁦Louise Emmett⁩ ⁦The Royal Australasian College of Physicians⁩

Enjoyed interviewing my physician colleagues Professors Sze Ting Lee and Michael Hofman at the Theranostics AANMS for the next The Royal Australasian College of Physicians President’s message (to all trainees - it was a very inspiring chat about nuclear medicine training!) RACPtrainees Kristof Wing Eddie Cliff

Live today on ProsTIC TV is our very own Kerry Jewell from Peter Mac Cancer Centre ! In this session recorded at #ProsTIC24, Dr Jewell shares her expertise on post-therapy imaging: Do we really need it? 🤔📝 Watch now or save for later: youtu.be/G_n4QIOsdAQ

Celebrating 10 years of PSMA PET/CT Peter Mac Cancer Centre Declan Murphy An incredible journey for research and our patients GU Cast | Urology podcast! ProsTIC PCF Science

10 years of PSMA PET/CT Peter Mac Cancer Centre and its cupcake time! Michael Hofman Declan Murphy ProsTIC #PSMA

The best title in the NET literature for the week: "May the Nuclear Medicine be with you!" Michael Hofman link.springer.com/article/10.100…

Interesting data on Terbium-161 vs Lutetium-177 internal conversion electrons increase nuclear dose & reduce cell survival and cell membrane damage from Terbium-161 also important jnm.snmjournals.org/content/early/… JNM

Peter Mac and ProsTIC's Michael Hofman joined 2GB Sydney this week to talk about the first targeted nuclear medicine for men with #prostatecancer to be approved by the TGA. Listen👇 youtu.be/b4u8CfOGi68

Navigating the future of #ProstateCancer care: AI-driven imaging and #theranostics through the lens of RELAINCE. ow.ly/V46h50Tfna0 #NuclearMedicine Michael Hofman